Community/Retail

Over the years, a number of landmark clinical studies in the field of psychiatry have been published, shaping how we treat mental illness. Here are 5 that every pharmacist should know about.

Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Pharmacists need to understand natural health products so that they can counsel patients, answer questions, and advise patients about potential drug interactions.

With tremendous advancements related to hepatitis B treatment in the last few years, the other types of hepatitis viruses are often overlooked.

This one piece of unlikely job advice has helped me tremendously throughout my career

We all want to learn more about psychology to better communicate with others, but we just don't have the time. Here is a summary of takeaways from the most influential psychologists in the field.

Medtronic's Intellis platform can record and track patient activity all day and is managed on the Samsung Galaxy Tab S2 tablet interface.

The FDA approval of this 5-nitroimidazole antimicrobial agent was supported by 2 studies of women with BV and an open label safety study, which found efficacy for single-dose secnidazole 2 g.

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV).

Grapefruit juice is not the only juice pharmacists should mention to patients.

Data showed a statistically significant increase in adherence to abstinence for the patients with alcohol, cocaine, marijuana and stimulant SUD in those who used Reset, 40.3%, compared to the patients who did not, 17.6%.

Pharmacists play an important role in keeping communities healthy during flu season. Take the time to listen to patients’ concerns, and be ready with recommendations.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Further clinical trials are required to confirm Aliqopa’s clinical benefit, and the sponsor is conducting these studies.

New biosimilars could play an important role in helping spur competition that can lower health care costs and increase access to important therapies.

Annually, the Journal of Pharmacy Practice publishes a list of the most significant publications covering infectious disease pharmacotherapy from the previous year.

Respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), affect more than 30 million American adults.

Learn about the new products and expanded indications approved by the FDA in August 2017.

Almost all persons infected with Campylobacter recover without any treatment, but some patients may require antimicrobial therapy.

Lower respiratory tract infections were associated with worse outcomes.

Pharmacists are in a prime position to help patients manage acute and chronic pain.

What tools should pharmacists use to help older people maintain adherence and understand their medications?

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses the most common misconceptions that patients have about pain.

The candidate vaccine is a nonlive, recombinant subunit vaccine to help prevent herpes zoster and its complications, such as postherpetic neuralgia, in adults 50 and older.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses whether the FDA should reduce the availability of high-dose opioids in response to the growing opioid abuse epidemic.

In Florida, many health care professionals learned how to prepare to serve in the face of calamity.